Study notes COVID-19 most likely caused by animal source, not of lab origin

Read more

Working with Moderna to see make its COVID vaccine available in India: Govt

Read more

Microbiome-targeting treatment is set to evolve, address multiple immunological indications: GlobalData

Read more

Rubicon Research acquires MeditabSpecialities’ facility in Satara, Maharashtra

Read more

Alembic Pharmaceuticals gets USFDA final approval for Erlotinib Tablets

Read more

Striving to increase vaccine availability through imports: Govt

Read more

Mankind Pharma gets DRDO nod to make and market 2-DG

Read more

Global adult epilepsy market to reach $8.35 billion by 2023: GlobalData

Read more

Sanofi, GSK get approval for Phase 3 COVID-19 vaccine trial in India

Read more

Alembic Pharma gets USFDA final nod for Desipramine Hydrochloride Tablets USP

Read more